Detecting Chemotherapeutic Skin Adverse Reactions in Social Health Networks Using Deep Learning
- 1 April 2018
- journal article
- letter
- Published by American Medical Association (AMA) in JAMA Oncology
- Vol. 4 (4), 581-583
- https://doi.org/10.1001/jamaoncol.2017.5688
Abstract
Adverse drug reactions (ADRs) occur in nearly all patients undergoing anticancer therapy, contributing to morbidity, therapy disruptions, and rising health care costs.1 Their identification and characterization are hampered by clinical trials that are underpowered to detect rare events, the division of patients across institutions, patient exclusion from trials, publication editorial delays, and lack of participation and planning in oncology clinical trials of medical disciplines outside of oncology. Postmarket drug surveillance platforms, such as US Food and Drug Administration (FDA) monitoring rely on voluntary, spontaneous reporting and lack temporal advantage over literature. Early recognition of ADRs could substantially improve health outcomes and decrease societal costs. Internet community health forums provide a mechanism for several hundred million individuals to discuss current health concerns and may serve as a resource for computational detection of ADRs. However, the language in social media is highly informal, and expressed medical concepts are often nontechnical, descriptive, and challenging to extract using dictionary-based methods.This publication has 5 references indexed in Scilit:
- Impact of Dermatologic Adverse Events on Quality of Life in 283 Cancer Patients: A Questionnaire Study in a Dermatology Referral ClinicAmerican Journal of Clinical Dermatology, 2013
- Description and management of cutaneous side effects during cetuximab or erlotinib treatments: A prospective study of 30 patientsJournal of the American Academy of Dermatology, 2006
- Erupción acneiforme por inhibidores del receptor de crecimiento epidérmicoActas Dermo-Sifiliograficas, 2005
- Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reportsPharmacoepidemiology and Drug Safety, 2001
- Reduced epidermal growth factor receptor expression in hypohidrotic ectodermal dysplasia and Tabby mice.JCI Insight, 1996